Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucositis: current management and investigations.

Adam S Garden1

  • 1Department of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA. Agarden@mdanderson.org

Seminars in Radiation Oncology
|August 7, 2003
PubMed
Summary

Preventing oral mucositis in head and neck cancer patients is crucial. Current research focuses on novel therapies targeting radiation-induced mucosal injury, aiming for better prevention strategies beyond symptom management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining a Quantitative Threshold for Adaptive Re-planning using a Percentile-based Scoring System.

International journal of particle therapy·2026
Same author

Designing an Electronic Patient-Reported Outcomes Information Infrastructure Supported by the RE-AIM Implementation Framework.

Advances in cancer education and quality improvement·2026
Same author

Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial.

Lancet (London, England)·2025
Same author

Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical Trials.

JAMA otolaryngology-- head & neck surgery·2025
Same author

Patient-reported outcomes after ipsilateral radiation therapy for N2b tonsillar squamous cell carcinoma.

Discover oncology·2025
Same author

Chemotherapy alone for stage II-IVa laryngeal squamous cell carcinoma: A 20-year follow-up.

Cancer·2025

Area of Science:

  • Oncology
  • Radiation Oncology
  • Cancer Therapeutics

Background:

  • Oral and pharyngeal mucositis are significant complications of head and neck cancer radiation therapy.
  • Incidence and severity increase with altered fractionation schedules and concurrent chemotherapy.
  • Current management relies heavily on symptom control, impacting patient quality of life and healthcare costs.

Purpose of the Study:

  • To review current and novel therapeutic strategies for preventing radiation-induced oral mucositis.
  • To explore mechanisms of mucosal injury and repopulation.
  • To highlight the need for targeted prevention over symptom management.

Main Methods:

  • Review of existing literature on mucositis prevention strategies.
  • Analysis of therapies targeting causative factors of mucositis.

Related Experiment Videos

  • Discussion of radioprotective agents and growth factor/cytokine manipulation.

    • Main Results:

    • Novel therapies aim to protect normal mucosa via direct radioprotection or by modulating growth factors and cytokines.
    • Approaches also address inflammation and infection as exacerbating factors.
    • No definitive preventive therapies have been established yet.

    Conclusions:

    • Understanding mucosal injury mechanisms is key to developing targeted prevention strategies.
    • Effective prevention will improve patient quality of life and reduce supportive care costs.
    • Future research should focus on specific, targeted interventions for mucositis prevention.